Stockreport

argenx Delivers on Promise to Transform Patient Expectations in Autoimmunity at American Academy of Neurology 2024 Annual Meeting [Yahoo! Finance]

Halozyme Therapeutics, Inc.  (HALO) 
Last halozyme therapeutics, inc. earnings: 2/24 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: halozyme.com/investors/default.aspx
PDF Abstracts reflect real-world value and consistent efficacy and safety profile associated with long-term use of VYVGART ® and VYVGART ® Hytrulo in gMG patients March 7 [Read more]